Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Michiko SUGAWARA"'
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Insomnia is highly comorbid in patients with psychiatric disorders, including depression, bipolar disorder, and substance use disorders, and should be treated as an independent condition. Dual orexin receptor antagonists (DORAs) have been in
Externí odkaz:
https://doaj.org/article/ab8a3f457ec3400ea66278dd7ff36b2a
Publikováno v:
eNeurologicalSci, Vol 25, Iss , Pp 100374- (2021)
To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patien
Externí odkaz:
https://doaj.org/article/160c2045227b4c5fb2abdf6b88488561
Autor:
Yoshikuni Tabata, Yoichi Imaizumi, Michiko Sugawara, Tomoko Andoh-Noda, Satoe Banno, MuhChyi Chai, Takefumi Sone, Kazuto Yamazaki, Masashi Ito, Kappei Tsukahara, Hideyuki Saya, Nobutaka Hattori, Jun Kohyama, Hideyuki Okano
Publikováno v:
Stem Cell Reports, Vol 11, Iss 5, Pp 1171-1184 (2018)
Summary: Parkinson disease (PD) is a progressive neurological disease caused by selective degeneration of dopaminergic (DA) neurons in the substantia nigra. Although most cases of PD are sporadic cases, familial PD provides a versatile research model
Externí odkaz:
https://doaj.org/article/fe1dd302708e4dc7827aa141f36e9904
Autor:
Hiromi MIYOSHI, Miki NISHIMURA, Yutaka YAMAGATA, Hao LIU, Yasuyoshi WATANABE, Michiko SUGAWARA
Publikováno v:
Journal of Biomechanical Science and Engineering, Vol 12, Iss 1, Pp 16-00613-16-00613 (2017)
Cell migration is an important process both in physiological and pathological conditions. Migrating cells in vivo respond to various extracellular environmental factors and change their migratory behavior. Thus, it is important to take into account e
Externí odkaz:
https://doaj.org/article/dece3f3883b5458ea10794529fb2aaf7
Autor:
Lijian XU, Atsushi SAITO, Yoko YOKOYAMA, Kenya SATO, Tatsuya SASAKI, Ryuhei YAMAGUCHI, Michiko SUGAWARA, Hao LIU
Publikováno v:
Journal of Biomechanical Science and Engineering, Vol 11, Iss 3, Pp 16-00117-16-00117 (2016)
Prediction of rupture status in cerebral aneurysms remains challenging for clinicians, and the important rupture indicator (wall shear stress, WSS) is controversially discussed. Recent studies report that flow instabilities appear to play an influent
Externí odkaz:
https://doaj.org/article/dddb649fd58b4370946a72b8cc8b0360
Publikováno v:
Journal of Biomechanical Science and Engineering, Vol 10, Iss 2, Pp 15-00015-15-00015 (2015)
A computational study of effects of vessel dynamics and compliance on coronary artery hemodynamics with / without stenosis is presented. The coronary artery hemodynamics with stenosis has been a main subject as one of the major cardiovascular disease
Externí odkaz:
https://doaj.org/article/26e0213f0dd74e30ab1f6ca47b57cc6e
Autor:
Takuji Okusaka, Masatoshi Kudo, Kenji Ikeda, Masafumi Ikeda, Kiwamu Okita, Michiko Sugawara, Toshiyuki Tamai, Min Ren, Kenichi Saito, Hiromitsu Kumada
Publikováno v:
Hepatology Research. 52:784-793
The phase III REFLECT study utilized bodyweight-based lenvatinib dosing in patients with unresectable hepatocellular carcinoma, based on results of the phase II Study 202. This post hoc analysis compared efficacy and safety in patients with lower and
Autor:
Yuta Yoshimura, Kenichi Nomoto, Javier Cortes, Toshiaki Saeki, Kenzo Muramoto, Seigo Nakamura, Junichiro Watanabe, Karenza Alexis, Yasuo Miyoshi, Michiko Sugawara, Jose Perez-Garcia, Kenichi Saito
Publikováno v:
Scientia
Breast Cancer (Tokyo, Japan)
Breast Cancer (Tokyo, Japan)
Background Eribulin, a nontaxane synthetic inhibitor of microtubule dynamics, is widely used to manage locally advanced or metastatic breast cancer (MBC). Eribulin has demonstrated immunomodulatory activity on the tumour microenvironment. Baseline ne
Autor:
Takahiro Osawa, Go Kimura, Yasuhisa Fujii, Yosuke Uchitomi, Kazunori Honda, Ariko Otani, Miki Kondo, Tetsuya Wako, Yoshihide Mitsuda, Daisuke Kawai, Michiko Sugawara, Hiromi Kitano, Nobuo Shinohara
Publikováno v:
Journal of Clinical Oncology. 41:702-702
702 Background: There is an increasing awareness of the importance of pt-centricity in cancer treatments. To achieve pt-centricity in mRCC treatment, it is important to clarify the differences of preferences between pts and physicians in terms of eff
Publikováno v:
eNeurologicalSci, Vol 25, Iss, Pp 100374-(2021)
eNeurologicalSci
eNeurologicalSci
To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patien